Bio-Tech Systems Market Report
U.S. sales of diagnostic radiopharmaceuticals reached $1.69 billion in 2005 and are expected to rise to $3.52 billion by 2012. Radiopharmaceutical sales grew 8.1% in 2005, diminishing somewhat from the previous year, but should resume growth in the range of 11%-12% per year. This forecast is based on the introduction of new products for cardiology and oncology and continued growth of PET imaging and sales of FDG. Sales of nuclear cardiology products will continue to drive the radiopharmaceutical market, with high utilization of nuclear perfusion studies coupled with advanced pharmacologic stress agents and introduction of new products for imaging myocardial infarction and congestive heart failure. Therefore, nuclear cardiology sales of $1.21 billion in 2005 will increase to $2.11 billion by 2012.  For additional information...

APhA Officer Election Results

Congratulations to the following individuals for the recent election as APhA officers.  We appreciate their time and talents to serve our profession!

New Election Cycle

Just as the announcement is made for the new APhA officers, it is now time to slate candidates for the next election cycle.  The APhA is changing the election cycle so that members will be able to meet the candidates at the APhA Annual Meeting and follow the same cycle as the Board of Trustees elections.  If you would like to serve the nuclear section as an officer applications are due by December 15th.  Watch www.aphanet.org for upcoming information.

 

BPS Approved Live CE at APhA Annual Meeting

Live continuing education hours applicable toward that which is required to maintain one's certification as a Board Certified Nuclear Pharmacist through the Board of Pharmaceutical Specialties has become a reality. This will happen for the first time at the upcoming APhA annual Meeting in Atlanta.  Fifteen hours of live CE credit will be offered for this meeting, of which five hours will be accepted for recertification.  More details about this process to come.

 

Hepatitis C Investigation Reported in JAMA Article

Health officials investigating the October 2004 outbreak of hepatitis C among 16 Baltimore-area recipients of a pharmacy-prepared radiopharmaceutical have reported in the recent issue of the Journal of the American Medical Association.  This is an important lesson for nuclear pharmacies handling biological products to follow appropriate aseptic technique to prevent contamination of sterile radiopharmaceuticals. To view this JAMA article...

APhA Members:  Join the Nuclear Pharmacy eCommunity Discussions at www.pharmacist.com